ОбзорГрафикПрофильОсновная статистикаФинансовые показателиНовостиTraderScreen

WORLDLINE S.A. EO -,68/  FR0011981968  /

gettex
23.05.2024  21:44:16 Изменение +0.055 Объем сделки Бид21:59:59 Предложение21:59:59 Рыночная капитализация Дивидендная доходность Коэффициент Цена/Доход
11.190EUR +0.49% 1,131
Оборот: 12,650.625		 11.115Величина цены спроса: 896 11.200Величина цены предложения: 896 3.17 млрдEUR - -
GlobeNewswire 23:11 Special Olympics Florida and Orlando Health Announce Five-Year Partnership
GlobeNewswire 23:10 Sensei Biotherapeutics Presents Promising Clinical Data from Phase 1 Dose Escalation Study of SNS-10...
GlobeNewswire 23:09 Ivy Brain Tumor Center announces Phase 0/2 clinical readout of niraparib indicating significant impr...
GlobeNewswire 23:06 G1 Therapeutics Announces Upcoming Presentation at the 2024 American Society of Clinical Oncology (A...
GlobeNewswire 23:05 Updated Phase 1 Clinical Data for SYS-6002 (CRB-701) to be presented at 2024 ASCO Annual Meeting
GlobeNewswire 23:05 BioAtla Presenting Phase 1 Evalstotug Clinical Trial Data Demonstrating Clinical Benefit at the Upco...
GlobeNewswire 23:05 I-Mab Announces Encouraging Phase 1 Clinical Data of PD-L1x4-1BB Bispecific Antibody Ragistomig at A...
GlobeNewswire 23:05 Compass Therapeutics to Present Phase 1 Data for CTX-471, A Novel CD137 Agonist Antibody, Demonstrat...
GlobeNewswire 23:05 Cogent Biosciences Appoints Cole Pinnow as Chief Commercial Officer
GlobeNewswire 23:05 FibroGen Announces Presentation of Positive Interim Data from the Phase 1b Study of FG-3246 (FOR46) ...
GlobeNewswire 23:05 NKGen Biotech Publishes Phase 1 Interim Analysis Results of SNK02 Allogeneic NK Cell Therapy in Adva...
GlobeNewswire 23:05 Elcora Announces Share Consolidation
GlobeNewswire 23:05 Affimed Announces Positive Early Efficacy and Progression Free Survival Results of AFM24-102 Study i...
GlobeNewswire 23:04 Cullinan Therapeutics to Present First Data for CLN-619, a Novel Anti-MICA/B Antibody, in Combinatio...
GlobeNewswire 23:03 Promising Anti-tumor Activity of Novel Costimulatory Bispecific Antibody REGN7075 (EGFRxCD28) in Com...
GlobeNewswire 23:01 Zentalis Pharmaceuticals to Present Promising Results from Phase 1 Trial of Azenosertib and Gemcitab...
GlobeNewswire 23:01 Cogent Biosciences Announces Positive Updated Lead-In Data from Ongoing Phase 3 PEAK Trial Evaluatin...
GlobeNewswire 23:01 HOOKIPA Pharma Announces Positive Clinical Data to be Presented at the American Society for Clinical...
GlobeNewswire 23:00 Arvinas Announces Upcoming Presentations at the 2024 American Society of Clinical Oncology Annual Co...
TeleTrader 23:00 Iran-backed militia claims drone attack on Eilat
GlobeNewswire 23:00 Theratechnologies’ Sudocetaxel Zendusortide ASCO 2024 Presentation Demonstrates Signs of Long-Term E...
GlobeNewswire 23:00 Iovance Biotherapeutics Announces Clinical Data in Frontline Advanced Melanoma at ASCO 2024 Annual M...
GlobeNewswire 23:00 Merus Announces Publication of Abstracts for Presentation at the 2024 ASCO® Annual Meeting
GlobeNewswire 23:00 MAQUIA CAPITAL ACQUISITION CORPORATION AND IMMERSED INC. MUTUALLY AGREE TO TERMINATE BUSINESS COMBIN...
GlobeNewswire 23:00 Merus Announces Publication of an Abstract on Petosemtamab with Pembrolizumab as 1L treatment of r/m...